-transparent.png){kind=logo}
Human erythrocytes (E) react by exocytosis of membrane vesicles to various stresses including the fixation of the membrane attack complex of Complement. E from normal individuals loose a notable proportion of their initial number of surface CR1 molecules during the ageing process. An acquired decrease of CR1 on E also occurs in pathological conditions such as Systemic Lupus Erythematosus or AIDS. The present study investigated whether calcium ionophore A23187 (Ca-ion) induced vesicle formation of human E in vitro is responsible for a preferential loss of CR1 as well as whether CR1 molecules at the surface of Ca-ion treated E or vesicles are: (i) functional, (ii) native or protease degraded, or (iii) more clustered than CR1 on native E. A study of E from 137 normal individuals showed that a one-hour Ca-ion induced vesicle formation preferentially removed one third of E surface CR1. Kinetic experiments suggested that all surface CR1 could be removed from E upon longer incubation times. CR1 molecules on vesicles were still able to inhibit Complement activation, and were found in larger clusters than on native E. These data suggest that a significant part of surface CR1 molecules may be removed from E by vesicle formation during the life of E in normal individuals. This phenomenon could be exacerbated in pathological conditions.
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
November 1988,
The Journal of experimental medicine,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
November 1997,
Clinical and experimental immunology,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
January 1999,
Molecular immunology,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
February 1981,
Journal of immunology (Baltimore, Md. : 1950),
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
March 1983,
Proceedings of the National Academy of Sciences of the United States of America,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
April 2004,
Molecular immunology,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
May 1992,
Journal of biochemistry,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
January 1987,
Scandinavian journal of rheumatology,
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
January 1990,
Journal of immunology (Baltimore, Md. : 1950),
X Dervillez, and
S Oudin, and
M T Libyh, and
T Tabary, and
B Reveil, and
F Philbert, and
F Bougy, and
M Pluot, and
J H Cohen
January 1990,
Autoimmunity,
